Globant, a digitally native company focused on reinventing businesses through innovative technology solutions, announced the launch of its new retail-oriented ...

Vertex Pharmaceuticals is marching beyond its cystic fibrosis stronghold with bold steps into pain management and genetic ...

Equity markets started 2025 pretty well, but things haven't been so rosy in the past couple of months. The tech-heavy Nasdaq ...

Artificial general intelligence may be years away, but in the meantime, organisations are being urged to adopt agent ...

But it's logical to ask: What's Vertex's long-term story? Where will the company be in 10 years, for example? Let's find out. Where to invest $1,000 right now? Our analyst team just revealed what ...

But it's logical to ask: What's Vertex's long-term story? Where will the company be in 10 years, for example? Let's find out. First, a bit of background on Vertex's CF program since it's so ...

NASA’s Mars Sample Return (MSR) mission promises to fill significant gaps in our understanding of the universe and propel humanity forward in a new phase of the space race. Exploring the cosmos ...

And for those that are in pain, for example, ensuring that we are contracting and pricing in a way that is both responsibly balances access, but also preserving value for Vertex for the long term.

Journavx works differently than other available medications, and its developer, the biotechnology juggernaut Vertex Pharmaceuticals, has positioned it as an important, non-opioid option for pain ...

Google Cloud's Vertex AI Search for Healthcare tool is ... Google Cloud gives the example that the technology could receive a diagram of a patient's feet indicating where they have an injury ...

At Vertex, I’ve known Duncan 30 years ... And we’ve actually gotten quite far in that journey, as you know, ALYFTREK, for example the six to 11 study over 50% of the people in that study ...